The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma

• Renaud Grépin,

  Affiliation Biomedical Research Unit, Centre Scientifique of Monaco, Principality of Monaco

  ⨯
• Damien Ambrosetti,

  Affiliation Institute for Research on Cancer and Aging of Nice (IRCAN) UMR/7284 U1081, Nice University Hospital, Central Laboratory of Pathology, University of Nice Sophia Antipolis, Nice, France

  ⨯
• Alexandre Marsaud,

  Affiliation Institute for Research on Cancer and Aging of Nice (IRCAN) UMR/7284 U1081, Nice University Hospital, Department of Urology, University of Nice Sophia Antipolis, Nice, France

  ⨯
• Lauris Gastaud,

  Affiliation Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France

  ⨯
• Jean Amiel,

  Affiliation Nice University Hospital, Department of Urology, University of Nice Sophia Antipolis, Nice, France

  ⨯
• Florence Pedeutour ,

  Contributed equally to this work with: Florence Pedeutour, Gilles Pagès

  Affiliation Institute for Research on Cancer and Aging of Nice (IRCAN) UMR/7284 U1081, Nice University Hospital, Laboratory of Solid Tumors Genetics, University of Nice Sophia Antipolis, Nice, France

  ⨯
• Gilles Pagès

  Contributed equally to this work with: Florence Pedeutour, Gilles Pagès

  * E-mail: gpages@unice.fr

  Affiliation Institute for Research on Cancer and Aging of Nice (IRCAN) UMR/7284 U1081, University of Nice Sophia Antipolis, Nice, France

  ⨯